Safety profile of baricitinib in patients with systemic lupus erythematosus: an integrated analysis

Safety profile of baricitinib in patients with systemic lupus erythematosus: an integrated analysis

Objectives To assess the safety of the oral Janus kinase inhibitor baricitinib in adult patients with systemic lupus erythematosus (SLE) receiving stable background therapy. Topics of special interest included infections and cardiovascular and thromboembolic events.Methods This analysis included int...

Full description

Bibliographic Details
Main Authors: Josef S Smolen, Yoshiya Tanaka, Michelle Petri, Inmaculada de la Torre, Thomas Dörner, Gabriella Meszaros, Hong Zhang, Maher Issa, Eric Morand, Christina Dickson, Maria Silk
Format: Article
Language:English
Published: BMJ Publishing Group 2023-08-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/9/3/e003302.full

Internet

https://rmdopen.bmj.com/content/9/3/e003302.full

Similar Items